Toronto Dominion Bank’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,131,390
Closed -$3.63M 1899
2025
Q1
$3.63M Buy
+2,131,390
New +$8M 0.01% 774
2021
Q1
Sell
-23,512
Closed -$236K 1502
2020
Q4
$236K Buy
+23,512
New +$233K ﹤0.01% 1009

Other funds holding HUMA

Toronto Dominion Bank's HUMA Position: Q2 2025 in Review

Toronto Dominion Bank sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 2,131,390 shares — an estimated $3.63M sold.

Toronto Dominion Bank first reported a position in HUMA in Q4 2020 and held it in 2 quarters. The position peaked at $3.63M in Q1 2025. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • Toronto Dominion Bank reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 2,131,390 Humacyte shares in Q2 2025, an estimated $3.63M.
  • Toronto Dominion Bank first reported a position in Humacyte in Q4 2020 and held it in 2 quarters.
  • Toronto Dominion Bank's Humacyte position peaked at $3.63M in Q1 2025.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on Toronto Dominion Bank's 13F filing for Q2 2025, filed 14 Aug 2025.